Skip to main content
. Author manuscript; available in PMC: 2019 Aug 6.
Published in final edited form as: Eur Respir J. 2019 Apr 18;53(4):1802237. doi: 10.1183/13993003.02237-2018

Table 5.

Baseline characteristics of the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) cohort (n=7083)

Characteristic Result
Age at diagnosis years 56±12
Male sex 4371 (62)
Ethnicity
 Caucasian 6763 (96)
 African-american 106 (1)
 Other 214 (3)
BMI class kg-m−2
 <18.5 464 (7)
 18.5−24.9 3060 (43)
 25−29.9 2376 (33)
 ≥30 1183 (17)
Diagnosis delay years 0.8 (0.4−1.3)
Symptom onset site
 Limb 5517 (78)
 Bulbar 1566 (22)
FVC % predicted 88±20
ALSFRS-R total score 37±6
ALSFRS-R dyspnoea score
 4 4887 (69)
 3 1133 (16)
 2 779 (1 1)
 1 213 (3)
 0 71 (1)
ALSFRS-R orthopnoea score
 4 5902 (84)
 3 708 (10)
 2 334 (5)
 1 71 (1)
 0 48 (<1)

Data are presented as n (%), mean±SD or median (interquartile range). BMI: body mass index; FVC: forced vital capacity; ALSFRS-R: amyotrophic lateral sclerosis functional rating scale-revised.

HHS Vulnerability Disclosure